Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3742 (113th)

Antibiotic Development to Advance Patient Treatment Act of 2013

referredUnited States· United States Congress· EN

Introduced

12 December 2013

Last action

13 December 2013 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Gingrey, Phil [R-GA-11], Rep. Green, Gene [D-TX-29], Rep. Shimkus, John [R-IL-15], Rep. Eshoo, Anna G. [D-CA-18], Rep. Whitfield, Ed [R-KY-1], Rep. DeGette, Diana [D-CO-1], Sen. Blackburn, Marsha [R-TN], Rep. Engel, Eliot L. [D-NY-16], Rep. Griffith, H. Morgan [R-VA-9], Rep. Butterfield, G. K. [D-NC-1], Rep. Matsui, Doris O. [D-CA-7], Rep. Ellmers, Renee L. [R-NC-2], Rep. Dingell, John D. [D-MI-12], Rep. Latta, Robert E. [R-OH-5], Rep. Matheson, Jim [D-UT-2], Sen. Cassidy, Bill [R-LA], Rep. Yarmuth, John A. [D-KY-3], Rep. Olson, Pete [R-TX-22], Rep. Tonko, Paul [D-NY-20], Rep. Lance, Leonard [R-NJ-7], Rep. Pompeo, Mike [R-KS-4], Rep. Barrow, John [D-GA-12], Rep. Guthrie, Brett [R-KY-2], Sen. Luján, Ben Ray [D-NM], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Speier, Jackie [D-CA-14], Rep. Shea-Porter, Carol [D-NH-1], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Roskam, Peter J. [R-IL-6], Rep. McCaul, Michael T. [R-TX-10], Rep. Barton, Joe [R-TX-6], Rep. Langevin, James R. [D-RI-2], Rep. McNerney, Jerry [D-CA-9], Rep. Roe, David P. [R-TN-1], Rep. Byrne, Bradley [R-AL-1], Rep. Pascrell, Bill, Jr. [D-NJ-9], Rep. Johnson, Eddie Bernice [D-TX-30], Rep. Heck, Joseph J. [R-NV-3], Rep. DesJarlais, Scott [R-TN-4], Rep. Ellison, Keith [D-MN-5], Rep. Kilmer, Derek [D-WA-6], Rep. Conaway, K. Michael [R-TX-11], Rep. Flores, Bill [R-TX-17], Rep. Takano, Mark [D-CA-39], Rep. Tipton, Scott R. [R-CO-3], Rep. Scott, Austin [R-GA-8], Rep. Clarke, Yvette D. [D-NY-9], Rep. Joyce, David P. [R-OH-14]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Antibiotic Development to Advance Patient Treatment Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to authorize the Secretary of Health and Human Services (HHS) to approve the use of an antibacterial or antifungal drug that is intended for treatment of a serious or life-threatening disease or condition to treat a limited population of patients for which there is an unmet medical need. Requires the labeling of such drugs to prominently include in the prescribing information the statement that the drug is indicated for use in a limited and specific population of patients. Amends the Public Health Service Act to authorize the Secretary to license those antibacterial or antifungal drugs as biological products. Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) monitor the use of antibacterial and antifungal drugs, (2) monitor changes in bacterial and fungal resistance to drugs, and (3) make the information derived from such monitoring available to the public. Amends the FFDCA to direct the Secretary: (1) to identify upon approval, and subsequently update, susceptibility test interpretive criteria for antibacterial drugs by relying upon preclinical and clinical data, Bayesian and pharmacometric statistical methodologies, and such other confirmatory evidence the Secretary deems necessary; (2) on a quarterly basis, to evaluate new or updated criteria published by a nationally or internationally recognized standard development organization; and (3) to publish on the Food and Drug Administration's (FDA's) website a notice adopting, declining to adopt, or partially adopting such new or updated criteria.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 12 December 2013

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 12 December 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 12 December 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 13 December 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 12 December 2013

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 12 December 2013

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 12 December 2013

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 54 sponsors and actors.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.